Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
A study designed to assess the safety and tolerability, pharmacokinetics, and pharmacodynamics of CT-996 in overweight/obese participants and participants with T2DM.
Epistemonikos ID: 5462a4bfb042912c65c1ce7aa85ac9d1c6c7bcef
First added on: Feb 19, 2024